Tumor cells secreting high levels of IL-6 and MIP-1α were found to be recruited to the bone marrow, where the balance between osteoblasts and osteoclasts was altered, leading to a series of changes in the endosteal and vascular niches. Here, CCL3 is linked to neoplasm.